Rubiya Kausar, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kausar’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A171350 · Current
Licensed to practise in California · since 2021 · expires 2027-01-31 · Rajiv Gandhi University of Health Sciences, Bangalore Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$46,630
Medicare paid this office $46,630 for 111 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 83 | $25,318 | $113 |
| Long return visit (40+ min) | 29 | $6,258 | $142 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 81 | $3,047 | $15 |
| Short return visit (20+ min) | 23 | $2,292 | $72 |
| New patient visit (45+ min) | 15 | $1,602 | $107 |
See all 8 services
| Return visit (30+ min) | 83 | $25,318 | $113 |
| Long return visit (40+ min) | 29 | $6,258 | $142 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 81 | $3,047 | $15 |
| Short return visit (20+ min) | 23 | $2,292 | $72 |
| New patient visit (45+ min) | 15 | $1,602 | $107 |
| Influenza vaccine split virus, preservative free | 15 | $1,279 | $80 |
| Administration of influenza virus vaccine | 16 | $703 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $211 | $10 |
Who their Medicare patients are
111 Original Medicare patients in 2024. Average age 75 · Women 81% · Also on Medicaid 16% · Health risk score 1.32. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 38% · Chronic kidney disease 29% · Depression 22% · Coronary heart disease 21% · Cancer 15% · Atrial fibrillation 15% · Heart failure 14% · Dementia 10%.
The office billed $190,743, Medicare allowed $63,592 and paid $46,630; for 649 services of 32 kinds; $3,721 of it was for drugs given in the office and $42,909 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 111 | 649 | 75 | 1.32 | $190,743 | $46,630 |
| 2023 | 98 | 417 | 75 | 1.28 | $152,508 | $36,503 |
| 2022 | 113 | 248 | 73 | 1.03 | $79,872 | $19,375 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 64 | $15,172 | $111 |
| Long return visit (40+ min) | 29 | $6,090 | $156 |
| Short return visit (20+ min) | 34 | $4,462 | $78 |
| New patient visit (45+ min) | 31 | $3,479 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,027 | $156 |
| Influenza vaccine split virus, preservative free | 11 | $784 | $71 |
| Administration of influenza virus vaccine | 14 | $517 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $312 | $12 |
2022: 4 services
| Return visit (30+ min) | 39 | $6,310 | $117 |
| Short return visit (20+ min) | 45 | $5,134 | $83 |
| New patient visit (30+ min) | 25 | $1,934 | $77 |
| New patient visit (45+ min) | 16 | $1,679 | $105 |
Drugs they prescribed that Part D paid
$239,198
Pharmacies billed $239,198 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (50 of 3,478) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
3,091 generic and 361 brand-name prescriptions · $239,198 in drug cost · 132 antibiotic prescriptions to 77 people · 30 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 42 | $47,075 | $1,121 |
| Jardiance | 33 | $36,094 | $1,094 |
| Rybelsus | 18 | $22,665 | $1,259 |
| Ozempic | 17 | $19,420 | $1,142 |
| Atorvastatin | 308 | $4,690 | $15 |
See all 74 drugs
| Eliquis | 42 | $47,075 | $1,121 |
| Jardiance | 33 | $36,094 | $1,094 |
| Rybelsus | 18 | $22,665 | $1,259 |
| Ozempic | 17 | $19,420 | $1,142 |
| Atorvastatin | 308 | $4,690 | $15 |
| Losartan | 183 | $2,683 | $15 |
| Midodrine | 12 | $1,968 | $164 |
| Levothyroxine | 122 | $1,968 | $16 |
| Lantus Solostar | 16 | $1,776 | $111 |
| Fluticasone-Salmeterol | 12 | $1,728 | $144 |
| Amlodipine Besylate | 168 | $1,625 | $10 |
| Lisinopril | 122 | $1,623 | $13 |
| Gabapentin | 114 | $1,478 | $13 |
| Metformin | 106 | $1,133 | $11 |
| Pantoprazole | 82 | $1,109 | $14 |
| Albuterol Sulfate Hfa | 38 | $1,014 | $27 |
| Humalog Kwikpen U-100 | 12 | $1,003 | $84 |
| Metformin Hcl Er | 76 | $908 | $12 |
| Repaglinide | 20 | $892 | $45 |
| Omeprazole | 44 | $772 | $18 |
| Diclofenac | 38 | $696 | $18 |
| Simvastatin | 52 | $682 | $13 |
| Clopidogrel | 28 | $650 | $23 |
| Olmesartan Medoxomil | 28 | $638 | $23 |
| Carvedilol | 56 | $610 | $11 |
| Losartan-Hydrochlorothiazide | 23 | $607 | $26 |
| Propranolol | 11 | $604 | $55 |
| Sertraline | 33 | $604 | $18 |
| Hydralazine | 38 | $578 | $15 |
| Escitalopram | 27 | $569 | $21 |
| Tamsulosin | 35 | $543 | $16 |
| Famotidine | 19 | $513 | $27 |
| Pravastatin | 26 | $481 | $19 |
| Metoprolol | 56 | $475 | $8 |
| Hydrocodone-Acetaminophen | 37 | $466 | $13 |
| Mirtazapine | 17 | $465 | $27 |
| Diltiazem 24hr Er (Cd) | 15 | $463 | $31 |
| Rosuvastatin | 22 | $456 | $21 |
| Metoprolol | 32 | $455 | $14 |
| Glipizide Er | 20 | $446 | $22 |
| Atenolol | 61 | $437 | $7 |
| Oxybutynin Chloride Er | 11 | $407 | $37 |
| Allopurinol | 23 | $364 | $16 |
| Valsartan | 14 | $343 | $25 |
| Benazepril | 20 | $330 | $17 |
| Hydrochlorothiazide | 57 | $300 | $5 |
| Glimepiride | 22 | $290 | $13 |
| Trazodone | 33 | $274 | $8 |
| Spironolactone | 21 | $238 | $11 |
| Furosemide | 38 | $232 | $6 |
| Isosorbide Mononitrate Er | 15 | $230 | $15 |
| Nitrofurantoin Mono-Macro | 27 | $219 | $8 |
| Alendronate | 14 | $216 | $15 |
| Meclizine | 31 | $212 | $7 |
| Montelukast | 13 | $207 | $16 |
| Fluticasone Propionate | 24 | $201 | $8 |
| Lisinopril-Hydrochlorothiazide | 17 | $196 | $12 |
| Triamcinolone Acetonide | 18 | $176 | $10 |
| Duloxetine | 21 | $152 | $7 |
| Cephalexin | 22 | $138 | $6 |
| Fluoxetine | 16 | $135 | $8 |
| Tizanidine | 22 | $127 | $6 |
| Amoxicillin-Clavulanate Potass | 27 | $125 | $5 |
| Glipizide | 12 | $123 | $10 |
| Benzonatate | 16 | $122 | $8 |
| Lactulose | 15 | $116 | $8 |
| Vitamin D2 | 13 | $113 | $9 |
| Zolpidem | 35 | $90 | $3 |
| Ibuprofen | 27 | $68 | $3 |
| Azithromycin | 17 | $61 | $4 |
| Quetiapine | 21 | $36 | $2 |
| Lorazepam | 15 | $26 | $2 |
| Sulfamethoxazole-Trimethoprim | 11 | $24 | $2 |
| Prednisone | 19 | $18 | $1 |
Year by year
| 2024 | 3,478 | 395 | 1% (50) | 10% | $239,198 |
| 2023 | 2,419 | 350 | 2% (46) | 12% | $213,277 |
| 2022 | 467 | 199 | None | 9% | $24,955 |
| 2020 | 206 | 29 | 0% (0) | 13% | $15,259 |
| 2019 | 585 | 63 | 0% (0) | 16% | $40,437 |
| 2018 | 349 | 41 | 0% (0) | None | $14,480 |
| 2017 | 41 | None | 0% (0) | None | $1,587 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Eliquis | 44 | $45,525 | $1,035 |
| Jardiance | 17 | $21,990 | $1,294 |
| Atorvastatin | 179 | $2,690 | $15 |
| Repaglinide | 18 | $1,686 | $94 |
| Oxybutynin Chloride Er | 13 | $1,483 | $114 |
| Losartan | 108 | $1,408 | $13 |
| Pregabalin | 11 | $1,336 | $121 |
| Gabapentin | 73 | $1,335 | $18 |
| Allopurinol | 14 | $1,323 | $95 |
| Amlodipine Besylate | 124 | $1,322 | $11 |
| Albuterol Sulfate Hfa | 35 | $1,265 | $36 |
| Divalproex | 11 | $1,172 | $107 |
| Levothyroxine | 73 | $1,153 | $16 |
| Lisinopril | 102 | $1,138 | $11 |
| Diclofenac | 35 | $1,105 | $32 |
| Temazepam | 13 | $921 | $71 |
| Hydrocodone-Acetaminophen | 32 | $783 | $24 |
| Pravastatin | 19 | $733 | $39 |
| Propranolol | 16 | $712 | $45 |
| Metformin | 69 | $651 | $9 |
| Omeprazole | 27 | $610 | $23 |
| Metoprolol | 27 | $598 | $22 |
| Hydralazine | 32 | $586 | $18 |
| Clopidogrel | 19 | $531 | $28 |
| Atenolol | 57 | $530 | $9 |
| Simvastatin | 37 | $507 | $14 |
| Pantoprazole | 40 | $436 | $11 |
| Famotidine | 19 | $422 | $22 |
| Escitalopram | 11 | $379 | $34 |
| Hydrochlorothiazide | 60 | $375 | $6 |
| Metoprolol | 37 | $371 | $10 |
| Cephalexin | 31 | $330 | $11 |
| Carvedilol | 37 | $311 | $8 |
| Lisinopril-Hydrochlorothiazide | 22 | $302 | $14 |
| Losartan-Hydrochlorothiazide | 13 | $295 | $23 |
| Paroxetine | 11 | $268 | $24 |
| Triamcinolone Acetonide | 21 | $255 | $12 |
| Glipizide Er | 11 | $249 | $23 |
| Ketoconazole | 11 | $248 | $23 |
| Zolpidem | 18 | $236 | $13 |
| Metformin Hcl Er | 30 | $219 | $7 |
| Benazepril | 14 | $208 | $15 |
| Alendronate | 19 | $200 | $11 |
| Sertraline | 12 | $193 | $16 |
| Tamsulosin | 18 | $184 | $10 |
| Trazodone | 28 | $177 | $6 |
| Furosemide | 44 | $171 | $4 |
| Amoxicillin-Clavulanate Potass | 17 | $166 | $10 |
| Synthroid | 11 | $158 | $14 |
| Oxycodone-Acetaminophen | 11 | $154 | $14 |
| Meclizine | 17 | $106 | $6 |
| Azithromycin | 12 | $89 | $7 |
| Sulfamethoxazole-Trimethoprim | 14 | $87 | $6 |
| Glipizide | 12 | $73 | $6 |
| Spironolactone | 12 | $71 | $6 |
| Glimepiride | 11 | $65 | $6 |
| Lorazepam | 15 | $11 | $1 |
2022: 9 drugs
| Losartan | 19 | $405 | $21 |
| Gabapentin | 16 | $335 | $21 |
| Omeprazole | 12 | $248 | $21 |
| Atorvastatin | 21 | $199 | $9 |
| Amlodipine Besylate | 18 | $132 | $7 |
| Paxlovid (Eua) | 12 | $123 | $10 |
| Lisinopril | 20 | $114 | $6 |
| Pantoprazole | 17 | $86 | $5 |
| Prednisone | 12 | $27 | $2 |
2020: 5 drugs
| Atorvastatin | 22 | $176 | $8 |
| Metformin | 24 | $114 | $5 |
| Gabapentin | 13 | $79 | $6 |
| Rosuvastatin | 11 | $57 | $5 |
| Amlodipine Besylate | 11 | $27 | $2 |
2019: 15 drugs
| Atorvastatin | 67 | $628 | $9 |
| Gabapentin | 17 | $327 | $19 |
| Nifedipine Er | 17 | $302 | $18 |
| Metformin | 33 | $195 | $6 |
| Ranitidine | 30 | $181 | $6 |
| Fluticasone Propionate | 14 | $142 | $10 |
| Tamsulosin | 13 | $135 | $10 |
| Losartan | 19 | $114 | $6 |
| Amlodipine Besylate | 27 | $99 | $4 |
| Simvastatin | 13 | $41 | $3 |
| Metoprolol | 13 | $40 | $3 |
| Lisinopril | 17 | $38 | $2 |
| Alendronate | 13 | $32 | $2 |
| Spironolactone | 11 | $29 | $3 |
| Hydrochlorothiazide | 16 | $19 | $1 |
2018: 11 drugs
| Atorvastatin | 32 | $340 | $11 |
| Metoprolol | 12 | $288 | $24 |
| Tamsulosin | 12 | $193 | $16 |
| Gabapentin | 11 | $141 | $13 |
| Fluticasone Propionate | 13 | $121 | $9 |
| Lisinopril | 25 | $95 | $4 |
| Ranitidine | 14 | $69 | $5 |
| Amlodipine Besylate | 11 | $58 | $5 |
| Metformin | 16 | $54 | $3 |
| Furosemide | 18 | $50 | $3 |
| Losartan | 14 | $46 | $3 |
Money from drug and device companies
$73 in 2025
| 2025 | 2 | 3 | None | $73 |
| 2024 | 2 | 3 | None | $56 |
| 2023 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $57 | 2 payments
|
| Amgen | Krystexxa | $16 | 1 payment
|
See all 3 published payments
| Exact Sciences | Meals · 2025-11-06 | Cologuard Collection Kit | $28 |
| Exact Sciences | Meals · 2025-03-19 | Cologuard Collection Kit | $29 |
| Amgen | Meals · 2025-01-08 | Krystexxa | $16 |
See earlier years (2024, 2023)
2024: $56
| Exact Sciences | Cologuard Collection Kit | $41 | 2 payments
|
| Amgen | Krystexxa | $15 | 1 payment
|
2023: $23
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
Professional record
- NPI
- 1053842542
- Licence
- CA A171350California A171350: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 227 N Jackson Ave, San Jose, CA, 95116
- NPI first listed
- 2017-03-25
- NPI last updated
- 2022-05-16
- NPI record certified
- 2022-05-16
This is when the NPI record was last certified, not a medical board exam.